Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001)
Author:
Funder
National Cancer Institute
Publisher
Elsevier BV
Subject
Obstetrics and Gynecology,Oncology
Reference31 articles.
1. Clear cell carcinoma of the ovary: a review of the literature;del Carmen;Gynecol. Oncol.,2012
2. Updates and emerging therapies for rare epithelial ovarian cancers: one size no longer fits all;Groen;Gynecol. Oncol.,2015
3. Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary;Crotzer;Gynecol. Oncol.,2007
4. Mechanisms of cisplatin resistance in clear cell carcinoma of the ovary;Itamochi;Oncology,2002
5. Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary;Itamochi;Obstet. Gynecol.,2002
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Proteomic landscape of epithelial ovarian cancer;Nature Communications;2024-07-31
2. Status and development of research on clear cell carcinoma of the ovary—a visualization-based bibliometric analysis;Translational Cancer Research;2024-06
3. Trends in survival of ovarian clear cell carcinoma patients from 2000 to 2015;Frontiers in Oncology;2024-03-07
4. From clinical management to personalized medicine: novel therapeutic approaches for ovarian clear cell cancer;Journal of Ovarian Research;2024-02-12
5. Comprehensive characterization of genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC: a single center experience;Journal of Gynecologic Oncology;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3